Pamela Stetkiewicz

Biography
Pamela Stetkiewicz, Ph.D., is Chief Executive Officer of Lyora Therapeutics and a biotechnology executive with more than two decades of experience in drug discovery and development. Her career spans scientific research, program leadership, business development, organizational design, and the advancement of therapeutic programs from early research into clinical development. Before joining Lyora, she held senior leadership roles at Arbor Biotechnologies, Flagship Pioneering, Editas Medicine, and the Novartis Institutes for Biomedical Research. Across these organizations, she has worked at the interface of emerging biology, platform technologies, portfolio strategy, and development execution. At Lyora, she is leading a company focused on genetic medicines for inherited retinal and sensory disorders, including programs that use RNA and gene-editing approaches to address disease-causing mutations. Dr. Stetkiewicz is known for building multidisciplinary teams and scalable development frameworks that connect scientific innovation with the operational and strategic requirements needed to move new medicines toward patients.